Real-life use of trametinib after immunotherapy failure in BRAF wild-type advanced melanoma : Melanoma Research

Journal Logo

Short communication

Real-life use of trametinib after immunotherapy failure in BRAF wild-type advanced melanoma

Pigné, Tristana; Lévy, Mariea; Ducharme, Océanea,b; Dutriaux, Carolinea,b; Gerard, Emiliea; Pham-Ledard, Annea,b; Beylot-Barry, Mariea,b; Prey, Sorillaa,b

Author Information
Melanoma Research ():10.1097/CMR.0000000000000884, March 15, 2023. | DOI: 10.1097/CMR.0000000000000884

Abstract

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid